Clinical-stage biotech company developing vaccines and
immunotherapies eliciting powerful CD8+ T Cells immune response
COMPANY
ABOUT US
EXECUTIVE COMMITTEE
SCIENTIFIC ADVISORY BOARD
CLINICAL ADVISORY BOARD
PARTNERS
SCIENCE
PIPELINE
OVERVIEW
INFLUENZA - OVX836
NEWS
PRESS RELEASES
MEDIA COVERAGE
PUBLICATIONS
EVENTS
CONTACT
LEGAL MENTIONS
COMPANY
ABOUT US
EXECUTIVE COMMITTEE
SCIENTIFIC ADVISORY BOARD
CLINICAL ADVISORY BOARD
PARTNERS
SCIENCE
PIPELINE
OVERVIEW
INFLUENZA - OVX836
NEWS
PRESS RELEASES
MEDIA COVERAGE
PUBLICATIONS
EVENTS
CONTACT
LEGAL MENTIONS